Synapse Biomedical, Inc.
Active in EUDAMEDUnited Statesfrom SRN EUDAMED SRN US-MF-000029893
Synapse Biomedical, Inc. is a medical device manufacturer based in the United States, with 72 devices listed in 4 registries (FDA Class III and II; EU Class IIa) and 2 FDA recalls as of 19 Nov 2026.
- Devices
- 72
- Registrations
- EUDAMED
- FDA recalls
- 2
Registry facts
- Registries
- FDA GUDID 69
- EUDAMED 2
- FDA 510(k) 1
- FDA PMA 1
- Device classes
- FDA Class III 54
- FDA Class II 16
- EU Class IIa 1
- Top EMDN categories
- FDA recalls
- Identifiers
- EUDAMED SRN US-MF-000029893
- DUNS 138432070
At a glance
EU certificates
1 of 1 in force.
Market reach
- European Union
- EUDAMED actor, 1 certificate
- United States
- FDA recalls
What Synapse Biomedical, Inc. makes
Synapse Biomedical, Inc. makes intramuscular diaphragm/phrenic nerve electrical stimulation systems, including external pulse generators, percutaneous stimulation leads, programmers, and active and return electrodes for these systems. Example devices include the NeuRx DPS™ External Pulse Generator, NeuRx DPS™ System Kit, Active Sensor Module, and related accessories such as sterile lead tunnelers, disposable electrode delivery tools, extended-life batteries, silicone adhesive kits, surface electrodes, and connector holder kits.
The company's devices are classified as Class II and Class III and are listed in the FDA 510(k), FDA PMA, and FDA UDI registries. Synapse Biomedical, Inc. is based in the United States.
Catalogue
Search and filter all 72 devicesShowing 1-50 of 72
Company details
- EUDAMED SRN
- US-MF-000029893
- DUNS number
- 138432070
- EUDAMED status
- Active
- EUDAMED registered name
- Synapse Biomedical, Inc.
- EUDAMED abbreviated name
- Synapse Biomedical
- Registered address
- 300, Artino Street, 44074, Oberlin, OH, United States
- Website
- synapsebiomedical.com
- Phone
- +1 440 774 2488 x137
- PRRC contact
- Jason Fiest
EUDAMED certificates
1 certificate1 valid, 0 expiredMDR 1next expiry 31 Mar 2031
BSI Group The Netherlands B.V. 2797 1 certificate
- MDR 791578 Active
Quality management system EU MDR
- Issued
- 1 Apr 2026
- Expires
- 31 Mar 2031
FDA recalls
FDA recall records list 2 recalls initiated by Synapse Biomedical, Inc., the earliest on 2022-05-31 and the most recent on 2022-07-11. By recorded status: 2 terminated. The reasons filed fall into these groups: labeling or instructions for use, packaging and performance or accuracy. A recall is often a precaution started by the manufacturer, and a count of records is not a verdict on a company.
Recalls initiated per year
- 2017 0
- 2018 0
- 2019 0
- 2020 0
- 2021 0
- 2022 2
- 2023 0
- 2024 0
- 2025 0
- 2026 0
2022
- 11 Jul 2022 Z-1561-2022 Class I Terminated Due to a defect identified on the EPG controller printed circuit board assembly, device performance may degrade over time. Depending on the failure mode, potential adverse events include pain, muscle fatigue and decreased breathing effectiveness, arrhythmia or cardiac arrest, or the device may stop unexpectedly.
Full distribution text
- 31 May 2022 Z-1393-2022 Class III Terminated Firm has revised labeling to consistently call out storage conditions and revised the instructions for use to clarify that the temperature range symbol is intended to indicate storage conditions (versus transport conditions or tolerance conditions for the package material).
- 11 Jul 2022 Z-1561-2022 Class I Terminated Due to a defect identified on the EPG controller printed circuit board assembly, device performance may degrade over time. Depending on the failure mode, potential adverse events include pain, muscle fatigue and decreased breathing effectiveness, arrhythmia or cardiac arrest, or the device may stop unexpectedly.
From the company website
NOCI envisions a future where effective use of outcome assessments drives the development of novel spinal care treatments. By collaborating with the Spinal Cord Injury (SCI) community, NOCI implements clinical discoveries that lead to impactful solutions and improved patient outcomes. Their services include customized clinical research, outcome measure development, training for healthcare professionals, and independent medical evaluations. As Synapse’s exclusive partner in Canada, NOCI is dedicated to promoting advanced respiratory care and delivering innovative solutions that enhance patient outcomes.
Frequently asked questions
How many devices does Synapse Biomedical, Inc. have in the registry?
The registry currently lists 72 devices for Synapse Biomedical, Inc.. Devices recorded under merged duplicate company entries are counted once.
Which registries list Synapse Biomedical, Inc.'s devices?
Among its 50 most recently registered devices, Synapse Biomedical, Inc. has devices listed in EUDAMED (1 device) and FDA GUDID (49 devices). A device can be listed in more than one registry, so these counts overlap.
What risk classes do Synapse Biomedical, Inc.'s devices fall under?
Among its 50 most recently registered devices, the classes recorded for Synapse Biomedical, Inc.'s devices are Class IIa, Class II and Class III. Each device page shows its own class and authorisation.
Are there FDA recall records for Synapse Biomedical, Inc.?
FDA recall records list 2 recalls initiated by Synapse Biomedical, Inc., the most recent initiated on 11 Jul 2022. A recall is often a precaution started by the manufacturer; the records say nothing about the company's overall record.
What EUDAMED certificates are recorded for Synapse Biomedical, Inc.?
EUDAMED lists 1 certificate for Synapse Biomedical, Inc. (quality management system) under MDR. 1 is recorded with the status issued. The most recent was issued on 1 Apr 2026.
What are the newest devices from Synapse Biomedical, Inc. in the registry?
The most recently registered devices listed for Synapse Biomedical, Inc. include TransAeris System, Clinical Kit, Synchrony 20-3001, Stimulator, Synchony 23-3000 and Sensor, Synchony 23-3001.